论文部分内容阅读
本月全球药品研发进展取得成效的药物有40个,比上月增加8个,除进入Ⅲ期临床研究阶段的药品数量较上月减少2个外,进入注册和注册前研究阶段的药品数量均有不同程度的增加。
There were 40 drugs that made progress in global drug research and development this month, an increase of 8 over the previous month. The number of drugs that entered the pre-registration and pre-registration phase was 2, except for the number of drugs entering the Phase III clinical research phase There are different degrees of increase.